U.S., Dec. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07302607) titled 'Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021' on Dec. 10.
Brief Summary: Although impressive progress has been made with this new therapeutic strategy, only a proportion of patients achieve a complete and sustained response. Studies have already identified predictive factors of treatment response that are now widely recognized. In this study, the investigators aim to identify other response factors not yet evaluated in the literature.
Study Start Date: Dec. 11, 2024
Study Type: OBSERVATIONAL
Condition:
Stage III Melanoma
Recruitment St...